olaparib
merck,astrazeneca
['brca', 'bcsm', 'breast']
#asco22 #bcsm highlights pre-specified ia2 of os from olympia adjuvant trial (high-risk her2-neg, gbrcam, any er-status #breastcancer) previously presented by dr. tutt et al at 2022 virtual plenary. 
Internist & oncologist serving ppl w/ cancer @ #bcsm clinic, #MedEd, #Regulatory & #COVID19. #ASCO20 Ed Chair. @HCWvsHunger. Not afraid to speak up. Go high.